Eagle Meds Services
Synagis (palivizumab)
Available to sourceHuman Prescription DrugRespiratory

Synagis (palivizumab)

100 mg/mL · Injection Solution
By Swedish Orphan Biovitrum AB (publ)
NDC
66658-231
Route
Intramuscular
Therapeutic class
Antibodies, Monoclonal [CS], Fusion Protein Inhibitors [MoA], Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody
Marketing category
BLA

Package sizes

  • 1 mL in 1 VIAL, SINGLE-DOSE (66658-231-01)NDC 66658-231-01Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request this medication

Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

Requesting
Synagis (palivizumab)
NDC 66658-231